At the news
? NEUTRALIMPACT 2/10 144 filed Jun 4, 2026 at 09:48 ET
Kristen Williams, an officer of Pacira BioSciences, filed a Form 144 intent to sell 10,259 shares of common stock, valued at approximately $228,468 based on a June 4, 2026 market price of $22.28. The shares were acquired through restricted stock vesting on June 3, 2026, as compensation. The sale is a routine post-vesting monetization by an officer, representing a small fraction of the company's $878M market cap, and does not signal material insider concern.
- Officer Kristen Williams filed Form 144 to sell 10,259 shares of PCRX common stock
- Proceeds estimated at ~$228,468 based on filing date price (~$22.28/share)
- Shares acquired via restricted stock vesting on June 3, 2026 (compensation)
- Sale executed through Fidelity Brokerage Services LLC
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access